The overall disease-controlled rate of acromegaly in our cohort was 45.9% when setting GH < 1.0 ng/ml and IGF-1 ULN ≤ 1.0 as the cutoff, which was relatively low among recent large-scale studies (46–75%) [4, 11, 23]. The gene discussed is GH1; the disease is acromegaly.